Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Investigative Ophthalmology & Visual Science|March 26, 2025
Genome-Wide Association Study to Identify Genetic Variants Associated With Diabetic MaculopathyRajya L Gurung, Charvi Nangia, Tengda Cai, et al.
Oncotarget|December 1, 2016
Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genesDanielle M Karyadi, Milan S Geybels, Eric Karlins, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 20, 2016
Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer RiskRobert J MacInnis, Daniel F Schmidt, Enes Makalic, et al.
The Prostate|January 25, 2017
Genome-Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case-Control StudyLiesel M FitzGerald, Haroon Naeem, Enes Makalic, et al.
Cancer Research|May 12, 2011
National Cancer Institute Prostate Cancer Genetics WorkshopWilliam J Catalona, Joan E Bailey-Wilson, Nicola J Camp, et al.
American Journal of Human Genetics|October 18, 2003
Mutations in a novel gene, NHS, cause the pleiotropic effects of Nance-Horan syndrome, including severe congenital cataract, dental anomalies, and mental retardationKathryn P Burdon, James D McKay, Michèle M Sale, et al.
British Journal of Cancer|August 5, 2016
Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control studyPierre-Antoine Dugué, Maree T Brinkman, Roger L Milne, et al.
British Journal of Cancer|August 3, 2017
Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortiumArtitaya Lophatananon, Sarah Stewart-Brown, Zsofia Kote-Jarai, et al.
British Journal of Cancer|February 14, 2018
Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortiumArtitaya Lophatananon, Sarah Stewart-Brown, Zsofia Kote-Jarai, et al.
Human Molecular Genetics|November 1, 2016
Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion statusManuel Luedeke, Antje E Rinckleb, Liesel M FitzGerald, et al.
Pageof 9